E-LIB Suche - Ergebnisse für: Pollyea, Daniel A

1

Frontline therapy of acute myeloid leukemia with lower inte..:

Marvin‐Peek, Jennifer ; Gilbert, Jason S. ; Pollyea, Daniel A..
American Journal of Hematology. , 2024

Link: https://doi.org/10.1002/..

2

Lysosomal acid lipase A modulates leukemia stem cell respon..:

Minhajuddin, Mohd ; Winters, Amanda ; Ye, Haobin...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

3

Venetoclax and hypomethylating agents in octogenarians and ..:

Madarang, Ellen ; Lykon, Jillian ; Zhao, Wei...
Blood Neoplasia. 1 (2024) 2 - p. 100016 , 2024

Link: https://doi.org/10.1016/..

4

Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Ph..:

Konopleva, Marina Y. ; Dail, Monique ; Daver, Naval G....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. 364-374 , 2024

Link: https://doi.org/10.1016/..

5

Safety, efficacy, and PK/PD of vorasidenib in previously tr..:

DiNardo, Courtney D. ; De Botton, Stéphane ; Pollyea, Daniel A....
American Journal of Hematology. 98 (2023) 9 - p. , 2023

Link: https://doi.org/10.1002/..

6

POSTER: AML-095 Findings From an Analysis of Patients With ..:

Konopleva, Marina ; DiNardo, Courtney ; Sun, Yan...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S156 , 2023

Link: https://doi.org/10.1016/..

7

AML-547 Prognostic Effect of Co-Mutations on Patients With ..:

Maciejewski, Jaroslaw ; Pollyea, Daniel ; Roboz, Gail...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S311-S312 , 2023

Link: https://doi.org/10.1016/..

8

Venetoclax and idasanutlin in relapsed/refractory AML: a no..:

Daver, Naval G. ; Dail, Monique ; Garcia, Jacqueline S....
Blood. 141 (2023) 11 - p. 1265-1276 , 2023

Link: https://doi.org/10.1182/..

9

Higher-dose venetoclax with measurable residual disease-gui..:

Gutman, Jonathan A. ; Winters, Amanda ; Kent, Andrew...
Haematologica. , 2023

Link: https://doi.org/10.3324/..

10

Transplantation Referral Patterns for Patients with Newly D..:

Tomlinson, Benjamin ; de Lima, Marcos ; Cogle, Christopher R....
Transplantation and Cellular Therapy. 29 (2023) 7 - p. 460.e1-460.e9 , 2023

Link: https://doi.org/10.1016/..

11

Multi-gene measurable residual disease assessed by digital ..:

Winters, Amanda C. ; Minhajuddin, Mohd ; Stevens, Brett M....
Haematologica. , 2023

Link: https://doi.org/10.3324/..

12

P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4..:

Dinardo, Courtney ; Pollyea, Daniel ; Aribi, Ahmed...
HemaSphere. 7 (2023) S3 - p. e605335a , 2023

Link: https://doi.org/10.1097/..

13

Venetoclax is safe and tolerable as post-transplant mainten..:

Kent, Andrew ; Schwartz, Marc ; McMahon, Christine...
Bone Marrow Transplantation. 58 (2023) 8 - p. 849-854 , 2023

Link: https://doi.org/10.1038/..

14

P521: FINDINGS FROM AN ANALYSIS OF PATIENTS WITH MONOCYTIC ..:

Konopleva, Marina ; D. Dinardo, Courtney ; Sun, Yan...
HemaSphere. 7 (2023) S3 - p. e160928c , 2023

Link: https://doi.org/10.1097/..

15

Venetoclax response prediction in acute myeloid leukemia: a..:

Stevens, Brett ; Pollyea, Daniel A.
Haematologica. 108 (2023) 7 - p. 1715-1717 , 2023

Link: https://doi.org/10.3324/..